Impact of obesity on renal structure and function in the presence and absence of hypertension: Evidence from melanocortin-4 receptor-deficient mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 297, Issue 3, 2009, Pages

  Do Carmo, Jussara M ^a   Tallam, Lakshmi S ^a   Roberts, John V ^a   Brandon, Elizabeth L ^a   Biglane, John ^a   Da Silva, Alexandre A ^a   Hall, John E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Metabolic syndrome; Renal injury; Salt sensitivity

Indexed keywords

COLLAGEN; MELANOCORTIN 4 RECEPTOR; N(G) NITROARGININE METHYL ESTER; TRANSFORMING GROWTH FACTOR BETA;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HYPERINSULINEMIA; HYPERLEPTINEMIA; HYPERTENSION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY STRUCTURE; LIPID ANALYSIS; MACROPHAGE; MEAN ARTERIAL PRESSURE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SALT INTAKE;

AGE FACTORS; ALBUMINURIA; ANIMALS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY WEIGHT; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; HEART RATE; HYPERINSULINISM; HYPERTENSION; KIDNEY; KIDNEY DISEASES; LEPTIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; RECEPTOR, MELANOCORTIN, TYPE 4; SODIUM CHLORIDE, DIETARY;

EID: 69249122492     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00187.2009     Document Type: Article

References (41)

1. Abrass CK, Spicer D, Raugi GJ. Induction of nodular sclerosis by insulin in rat mesangial cells in vitro: studies of collagen. Kidney Int 47: 25-37, 1995.
2. Abrass CK. Lipid metabolism and renal disease. Contrib Nephrol 151: 106-121, 2006.
3. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension, and Diabetes Executive Committees Working Group. Am J Kidney Dis 36: 646-661, 2000.
4. Bidani AK, Picken M, Hacioglu R, Williamson G, Griffin KA. Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance. Am J Physiol Renal Physiol 292: F647-F654, 2007.
5. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 65: 116-128, 2004.
6. Cohen MP, Lautenslager GT, Shearman CW. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice. Metabolism 50: 1435-1440, 2001.
7. Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 28: 127-132, 1996.
8. Dunn BR, Zatz R, Rennke HG, Meyer TW, Anderson S, Brenner BM. Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury. J Hypertens Suppl 4: S251-S254, 1986.
9. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844-850, 2004.
10. Fujiwara K, Hayashi K, Ozawa Y, Tokuyama H, Nakamura A, Saruta T. Renal protective effect of troglitazone in Wistar fatty rats. Metabolism 49: 1361-1364, 2000.
11. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, Gaziano JM. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46: 871-880, 2005.
12. Griffin KA, Abu-Amarah I, Picken M, Bidani AK. Renoprotection by ACE inhibition or aldosterone blockade is blood pressure dependent. Hypertension 41: 201-206, 2003.
13. Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci 324: 127-137, 2002.
14. Hall JE, Henegar JR, Dwyer TM, Liu J, da Silva AA, Kuo JJ, Tallam L. Is obesity a major cause of chronic renal disease? Adv Ren Replace Ther 11: 41-54, 2004.
15. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12: 1211-1217, 2001.
16. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006.
17. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141, 1997.
18. Humphreys MH. δ-MSH, sodium metabolism, and salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 286: R417-R430, 2004.
19. Jiang T, Wang Z, Proctor G, Moskowitz S, Liebman SE, Rogers T, Lucia MS, Li J, Levi M. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem 280: 32317-32325, 2005.
20. Kasiske BL, Crosson JT. Renal disease in patients with massive obesity. Arch Intern Med 146: 1105-1109, 1986.
21. Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis 46: 587-594, 2005.
22. Lavaud S, Poirier B, Mandet C, Belair MF, Irinopoulou T, Heudes D, Bazin R, Bariety J, Myara I, Chevalier J. Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats. Am J Physiol Renal Physiol 280: F683-F694, 2001.
23. Levine DZ, Iacovitti M, Robertson SJ, Mokhtar GA. Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 290: R975-R981, 2006.
24. Mauer SM, Steffes MW, Azar S, Sandberg SK, Brown DM. The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 27: 738-744, 1978.
25. Neuringer JR, Brenner BM. Hemodynamic theory of progressive renal disease: a 10-year update in brief review. Am J Kidney Dis 22: 98-104, 1993.
26. Nielsen S, Jensen MD. Relationship between urinary albumin excretion, body composition, and hyperinsulinemia in normotensive glucose-tolerant adults. Diabetes Care 22: 1728-1733, 1999.
27. Noda M, Matsuo T, Nagano-Tsuge H, Ohta M, Sekiguchi M, Shibouta Y, Naka T, Imura Y. Involvement of angiotensin II in progression of renal injury in rats with genetic non-insulin-dependent diabetes mellitus (Wistar fatty rats). Jpn J Pharmacol 85: 416-422, 2001.
28. Park SK, Kang SK. Renal function and hemodynamic study in obese Zucker rats. Korean J Intern Med 10: 48-53, 1995.
29. Poirier B, Lannaud-Bournoville M, Conti M, Bazin R, Michel O, Bariety J, Chevalier J, Myara I. Oxidative stress occurs in absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats. Nephrol Dial Transplant 15: 467-476, 2000.
30. Praga M, Hernandez E, Herrero JC, Morales E, Revilla Y, Diaz-Gonzalez R, Rodicio JL. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58: 2111-2118, 2000.
31. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54: 2012-2018, 2005.
32. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 26: 610-615, 1995.
33. Sierra C, de la Sierra A. Early detection and management of the high-risk patient with elevated blood pressure. Vasc Health Risk Manag 4: 289-296, 2008.
34. Tallam LS, da Silva AA, Hall JE. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48: 58-64, 2006.
35. Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension 46: 326-332, 2005.
36. Unger RH, Orci L. Lipotoxicity diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord 24: S28-S32, 2000.
37. Van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue ad lipotoxicity. Physiol Behav 94: 231-241, 2008.
38. Verhave JC, Hillege HL, Burgerhof JG, Navis G, de Zeeuw D, de Jong PE; Study Group PREVEND. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol 14: 1330-1335, 2003.
39. Weir MR, Fink JC. Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary. Am J Kidney Dis 45: 176-188, 2005.
40. Williams T, Chambers J, Roberts L, Henderson R, Overton J. Diet-induced obesity and cardiovascular regulation in C57BL/6J mice. Clin Exp Pharmacol Physiol 30: 769-778, 2003.
41. Wolf G, Ziyadeh FN. Leptin and renal fibrosis. Contrib Nephrol 151: 175-183, 2006.